In-Depth Study on Executive Summary Metagonimiasis Treatment Market Size and Share CAGR Value The global metagonimiasis treatment market size was valued at USD 320.50 billion in 2025 and is expected to reach USD 431.92 billion by 2033, at a CAGR of3.80% during the forecast period Trustworthy sources such as websites, journals, mergers, newspapers and other authentic sources have...

Triclabendazole is a highly effective antiparasitic medication primarily used for treating infections caused by liver flukes. It is especially known for its ability to target Fasciola hepatica and Fasciola gigantica, the parasites responsible for a disease called fascioliasis. Unlike many other antiparasitic drugs, which may work against a broad range of helminths, Triclabendazole has a unique...